Frank Harvey

Frank Harvey joined Surescripts as CEO in June 2022 after watching and appreciating the company’s work for many years. He recognizes the significant role Surescripts plays in moving healthcare forward and is helping the company continue leading the way. Throughout his tenure, Frank continually works closely with the Surescripts team on prioritizing the many opportunities they have as a company.

Frank’s leadership philosophy is to treat every person with respect, keep communication honest, and always have a bias for action. He believes in providing fun, fulfilling and challenging opportunities for employees, helping them stay motivated in delighting the customers.

Frank is an experienced chief executive and investor and has held numerous senior leadership roles during his more than 35-year career in the healthcare technology, pharmacy and pharmaceutical sectors. Most recently, Frank was with ATLS Investments LLC, where he led private equity investing in early-stage healthcare technology companies. Before that, Frank served as CEO of Mirixa Corporation, a leading medication management technology and services company. He also served as CEO of Liberty Medical Supply Inc., the nation’s largest provider of diabetic testing supplies. Earlier in his career, Frank held various management positions with Roche Pharmaceutical, Eli Lilly, Revco Drug Stores and Harte-Hanks, a leading direct marketing company.

Frank attended Virginia Tech as a chemistry major where he completed his pre-pharmacy work and then received his pharmacy degree from the Medical College of Virginia. Frank also has an MBA from the University of Phoenix and continued his professional development at the Wharton School of the University of Pennsylvania.

When Frank isn’t working, he and his wife support their local Boys & Girls Clubs. They are also passionate defenders of clean water, working with local organizations to address the significant issue of toxic algae